InPharmX Inc., DBA University Learning Systems Phone: 1-800-940-5860 Email: info@universitylearning.com
Professional learning online at a desk
← All on demand pharmacology CE/CME

On demand pharmacology CE/CME

Primary Care Update - Kauai -

FormatSelf-paced onlineRecordedOctober 9, 2024AccessAvailable now
Log in to register

About this course

Learn at your own pace.

NP25 Conference
New Drug Update Parts 1&2
Dr. Wendy Wright
Recorded October 10-11, 2024 in Kaui Hawaii


Educational information

Designed for meaningful, practical learning.

Sessions

Session
2024-10-10 New Drugs Part 2, Pediatric Pharmacotherapeutics, COVID –Drug Interactions, CKD Treatment in Primary Care

Thursday, October 10, 2024

Speaker: Dr. Wendy L. Wright Credit hours: 5 ACPE UAN: 0741-0000-24-025-H01-P

Learning objectives
  1. New Drugs Part 2, Pediatric Pharmacotherapeutics, COVID –Drug Interactions, CKD Treatment in Primary Care
  2. At the completion of this activity, the participant will be able to:
  3. New Drugs Part 2, 1) Identify 10 – 20 new medications 2) Discuss the use, side effects, drug-drug interactions, and benefits of each
  4. of the medications. 3)Discuss updates related to labeling, indications, risks associated with various medications.
  5. Pediatric Pharmacotherapeutics: 4)Identify ways in which children are different than adults in terms of pharmacotherapeutics . 5)
  6. Discuss common pediatric prescribing errors. 6)Discuss strategies to prevent pediatric prescribing errors. 7) Identify medications
  7. with new pediatric approvals. COVID–Drug Interactions-8. Improve ability to identify disparity gaps
  8. in treatment, management, and drug interactions in outpatients with COVID-19. 9) Gain greater confidence in their ability to assess
  9. and manage outpatients with COVID-19 for drug interactions. 10) Enhance their understanding of the national COVID-19 Treatment Guidelines for outpatients with COVID-19. CKD Treatment in Primary Care 11) Detect and recognize CKD in patients with
  10. reduced kidney function, including in early stages of disease. 12) Implement screening for albuminuria in patients with diabetes in
  11. clinical practice to identify CKD as early as p
2024-10-09 New Drugs Part 1, Obesity Case Studies, COPD, Fibromyalgia

Wednesday, October 9, 2024

Speaker: Dr. Wendy L. Wright Credit hours: 5 ACPE UAN: 0741-0000-24-024-H01-P

Learning objectives
  1. New Drugs Part 1,
  2. 1.) Identify 10 – 20 new medications .
  3. 2) Discuss the use, side effects, drug-drug interactions, and benefits of
  4. each of the medications.
  5. 3) Discuss updates related to labeling, indications, risks associated with various medications .
  6. Obesity Case Studies:
  7. 4) Discuss the health risks associated with obesity .
  8. 5) Identify the various behavioral modalities utilized to assist with
  9. weight loss .
  10. 6) Discuss pharmacologic strategies for weight stabilization or loss in the overweight or obese individual .
  11. COPD
  12. 7) Identify statistics regarding COPD.
  13. 8) Discuss the signs and symptoms of COPD.
  14. 9) Discuss treatment options for COPD .
  15. Fibromyalgia:
  16. 10)Identify new diagnostic criteria for fibromyalgia .
  17. 11) Discuss the various non-pharmacologic and pharmacologic treatments available for individuals with fibromyalgia .
  18. 12) Review multimodal treatments based upon the evidence .
Antibiotic Update: Respiratory Infections, New Therapies for Resistant Hypertension , OA and RA Guidelines 2023, Immunizations

Friday, October 11, 2024

Speaker: Dr. Wendy L. Wright Credit hours: 5 ACPE UAN: 0741-0000-24-026-H01-P

Learning objectives
  1. Antibiotic Update: Respiratory Infections, New Therapies for Resistant Hypertension , OA and RA Guidelines 2023, Immunizations
  2. At the completion of this activity, the participant will be able to:
  3. Antibiotic Update: Respiratory Infections: 1) Identify statistics related to incidence/prevalence of various respiratory conditions. 2)
  4. Discuss the signs and symptoms of pneumonia, ABRS, AOM, AECB. 3) Discuss treatment pharmacologic options for the above conditions.
  5. New Therapies for Resistant Hypertension: 4) Discuss the definition of resistant hypertension . 5) Identify the work up for the patient
  6. with resistant hypertension. 6) Discuss the treatment options for patient with resistant hypertension . OA and RA Guidelines 2023: 7)
  7. Discuss the pathophysiology of osteoarthritis and rheumatoid arthritis. 8) Identify the non-pharmacologic and pharmacologic agents
  8. available for the treatment of osteoarthritis and RA. 9) Compare and contrast newer pharmacologic agents with older agents with
  9. regard to benefits, risks, side effects, and drug interactions. Immunizations: 10) Identify the 2024 recommended vaccinations and
  10. schedule for individuals across the lifespan. 11) Discuss the benefits and side effects of the various vaccines for individuals across the
  11. lifespan. 12) Discuss strategies to improve vaccine hesitancy.

Faculty

Portrait of Dr. Wendy L. Wright, ULS faculty member

Dr. Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Family and Adult Nurse Practitioner · Wright & Associates Family Healthcare

An experienced nurse practitioner and nationally recognized educator whose teaching emphasizes current, practical primary-care pharmacology.

Professional profile ↗

Accreditation

Target audience

Pharmacists, Nurse Practitioners, Physicians, Physician Assistants, Nurses

PHARMACISTS

  • University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. 
  • These programs are accredited for all pharmacists.
  • This course provides 15 hours or 1.5 CEUs.
  • Credit for this course expires on October 9, 2027.

NURSES

  • This course provides 15 hours (1.5 CEU)
  • University Learning Systems is approved by the California Board of Registered Nursing, Provider Number CEP 11409, and CE Broker Tracking #50-11357:
  • University Learning Systems is approved by CE Broker for Florida, Georgia, Arkansas, District of Columbia, Georgia, New Mexico, and West Virginia, Boards of Nursing. 
  • The same hours submitted to renew NP certification may be submitted to a State Board of Nursing for re-licensure.

OTHER PROFESSIONS

  • CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

  • CANADIAN PHARMACISTS:Canadian Council on Continuing Education in Pharmacy (CCCEP)accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). 

  • CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians

  • Other healthcare professionals should confirm acceptance and reporting requirements with their licensing or certification board

Requirements and reporting

  • University Learning Systems reports pharmacy credit through CPE Monitor using the participant’s eNABPID number and date of birth.
  • University Learning Systems is approved by CE Broker, for pharmacy, medicine and nursing for participating states,  Tracking #50-11357. Participant's state license number is required for reporting.
  • Credit is based on completed evaluations for registered sessions. 
  • Credit is awarded per session; partial session credit is not available, and breaks are excluded.
  • Other eligible participants receive an applicable statement of credit after completing the required documentation.

Review complete ULS accreditation statements →

Course fees

DescriptionPrice
Default 15 Hours$250

Begin today

Ready when you are.

Log in to register